Comparing Saxenda vs Toujeo SoloStar
Saxenda (liraglutide) | Toujeo SoloStar (insulin glargine) |
|
---|
Saxenda (liraglutide) | Toujeo SoloStar (insulin glargine) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Weight Loss (Obesity/Overweight). Saxenda may also be used for purposes not listed in this medication guide. |
Prescription only
Toujeo Solostar contains insulin glargine in a prefilled pen at a higher concentration (300 units per mL) than other forms of insulin glargine, such as Lantus Solostar, and one pen contains 450... View more |
||||||||
More about Saxenda (liraglutide) | More about Toujeo SoloStar (insulin glargine) | ||||||||
Ratings & Reviews | |||||||||
Saxenda has an average rating of 7.5 out of 10 from a total of 1450 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 14% reported a negative effect. |
Toujeo SoloStar has an average rating of 4.1 out of 10 from a total of 46 ratings on Drugs.com. 22% of reviewers reported a positive effect, while 57% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Saxenda side effects |
View all Toujeo SoloStar side effects |
||||||||
Drug Class | |||||||||
Generic Availability | |||||||||
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Saxenda prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | |||||||||
|
|
||||||||
Brand Names | |||||||||
Other liraglutide brands include: Victoza | Other insulin glargine brands include: Basaglar, Lantus, Lantus SoloStar, Rezvoglar, Semglee, Toujeo Max SoloStar | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
13 hours |
24 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category C
Risk cannot be ruled out
Victoza
Category X
Not for use in pregnancy
Saxenda See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 274 drugs are known to interact with Saxenda:
|
A total of 394 drugs are known to interact with Toujeo SoloStar:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
|
|||||||||
Disease Interactions | |||||||||
First Approval Date | |||||||||
N/A |
February 25, 2015 |
||||||||
WADA Class View classifications | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient Resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Zepbound
Zepbound (tirzepatide) is an FDA-approved weekly injection for weight loss and obstructive sleep ...
Victoza
Victoza helps control blood sugar levels and reduce the risk of serious heart problems in people ...
Contrave
Contrave is an anorexiant and is used to help manage weight in obese or overweight adults with ...
Qsymia
Qsymia (phentermine and topiramate) is used together with diet and exercise to treat obesity ...
Adipex-P
Adipex-P (phentermine) is an appetite suppressant used togther with diet and exercise to treat ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.